文献速递关节外科运动医学

临界性髋关节发育不良患者髋关节镜术后结局的性别差异:倾向匹配比较研究

Sex-Based Differences in Outcomes, Clinical Benefit, and Survivorship in Patients With Borderline Hip Dysplasia Undergoing Hip Arthroscopy at a Minimum 5-Year Follow-up: A Propensity-Matched Comparison Study.
PubMed 文献 · Am J Sports Med · 2026-03-13

本研究回顾性纳入2008至2018年接受初次髋关节镜手术、LCEA在18°至25°之间的临界性髋关节发育不良患者,按性别进行1:1倾向匹配(匹配年龄、BMI和Tönnis分级),最终152髋(每组76髋)。至少5年随访显示,两组患者报告结局均显著改善且组间相当,但女性在MCID、PASS和MOI达成率上显著更高,而假体生存率无显著性别差异。

要点

  • 女性在mHHS、NAHS和VAS疼痛的MCID达成率以及mHHS的PASS达成率上显著高于男性。
  • 女性在NAHS的MOI达成率显著高于男性,其余MOI指标组间无显著差异。
  • 至少5年随访时,男性和女性的假体生存率相似,无显著差异。

核心结论

  • 至少5年随访时,临界性髋关节发育不良患者髋关节镜术后PROMs和假体生存率在男女间相当,但女性临床获益达成率显著更高。

研究设计与样本

  • 回顾性队列研究,证据等级3级;纳入2008至2018年接受初次髋关节镜手术、LCEA 18°至25°的临界性髋关节发育不良患者,排除LCEA<18°或>25°、同侧髋手术史或病变、Tönnis分级>1者;按性别1:1倾向匹配(匹配年龄、BMI和Tönnis分级),最终152髋(每组76髋)。

主要发现

  • 两组所有PROMs在至少5年随访时均显著改善且组间相当,MCID、PASS和MOI达成率均较高。

关键数值与推荐

  • 临界性髋关节发育不良定义为LCEA在18°至25°之间。
  • 临床获益评估采用MCID、PASS和MOI;生存率定义为未转为全髋关节置换术。

临床怎么用

  • 对于LCEA在18°至25°的临界性髋关节发育不良患者,髋关节镜术后至少5年时男女均有显著改善和较高生存率,女性在MCID、PASS和MOI达成率上更优,可用于术前咨询和预期管理。

局限性

  • 回顾性研究设计,证据等级3级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data on midterm outcomes in patients with borderline hip dysplasia (BHD) based on sex differences after hip arthroscopy are scarce. PURPOSE: To report sex-based differences in patient-reported outcome measures (PROMs), clinical benefit, and survivorship in patients with BHD who underwent hip arthroscopy at a minimum 5-year follow-up. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Data were retrospectively reviewed for all patients with BHD who underwent primary hip arthroscopy with a lateral center-edge angle (LCEA) between 18° and 25° from 2008 to 2018. The exclusion criteria were as follows: LCEA <18º or >25º, previous ipsilateral hip surgery or conditions, and Tönnis grade >1. The modified Harris Hip Score (mHHS), Non-arthritic Hip Score (NAHS), and visual analog scale (VAS) for pain and patient satisfaction were reported. Clinical benefit was assessed via minimal clinically important difference (MCID), the patient acceptable symptomatic state (PASS), and the maximum outcome improvement (MOI). Survivorship was defined as nonconversion to total hip arthroplasty. A sex-based propensity-matched comparison was made in a 1-to-1 ratio based on age, body mass index (BMI), and Tönnis grade. RESULTS: Propensity-score matching created a cohort of 152 hips, 76 per group. Significant and comparable improvements in all PROMs were observed at a minimum 5-year follow-up, with high achievement rates for the MCID, PASS, and MOI in both groups. However, improvements were significantly higher for women for MCID for the mHHS (86.8% vs 69.7%; P = .0105), MCID for the NAHS (88.2% vs 61.8%; P = .0002), MCID for the VAS for pain (84.2% vs 64.5%; P = .005), PASS for the mHHS (90.8% vs 78.9%; P = .041), and MOI for the NAHS (77.6% vs 55.3%; P = .0057). Survivorship was similar for men (94.74%) and women (89.47%) (P = .229). CONCLUSION: At a minimum 5-year follow-up, a propensity-matched comparison of female and male patients with BHD who underwent primary hip arthroscopy demonstrated significant improvement and comparable PROMs and survivorship. Clinical benefit was significantly higher in women, as evidenced by higher achievement rates on the MCID, PASS, and MOI.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Maldonado DR, Walsh EG, Schab AR, et al. Sex-Based Differences in Outcomes, Clinical Benefit, and Survivorship in Patients With Borderline Hip Dysplasia Undergoing Hip Arthroscopy at a Minimum 5-Year Follow-up: A Propensity-Matched Comparison Study. Am J Sports Med. 2026. PMID: 41823323. doi:10.1177/03635465251410548

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。